Dengue Vaccine Market 2027 By Product, Distribution Channel and Geography | The Insight Partners

Dengue Vaccine Market to 2027 - Global Analysis and Forecasts By Product (CYD-TDV); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Others) and Geography

Report Code: TIPRE00006927 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Dengue is a vector-borne disease caused due to virus that belongs to the Flaviviridae family and genus Flavivirus. Dengue fever is developed to a person who is bitten by infected Aedes aegypti mosquito. The symptoms of dengue disease include fever, headache, fatigue, muscle pain, diarrhea, anemia, skin rashes, and vomiting.

MARKET DYNAMICS

The dengue vaccine market is anticipated to grow in the forecast, owing to the factors such as increasing prevalence of the diseases, large unmet medical need for managing dengue burden, promising end stage vaccine, adoption of dengue vaccines by several countries, and promising end stage vaccine pipeline. Nevertheless, cold chain systems for storage of vaccine in resource constrained countries is expected to hamper the market growth during the forecast period.

MARKET SCOPE

The "Global Dengue Vaccine Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of dengue vaccine market with detailed market segmentation by product, distribution channel and geography. The global dengue vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading dengue vaccine market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global market is segmented on the basis of product and distribution channel. Based on product the market is segmented into CYD-TDV. Based on distribution channel the market is segmented into hospitals pharmacies, retail pharmacies, drug stores, online pharmacies, and others.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global dengue vaccine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The dengue vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting dengue vaccine market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Dengue Vaccine market in these regions.

MARKET PLAYERS


The reports cover key developments in the dengue vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from dengue vaccine market are anticipated to lucrative growth opportunities in the future with the rising demand for dengue vaccine market in the global market. Below mentioned is the list of few companies engaged in the dengue vaccine market.

The report also includes the profiles of dengue vaccine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Sanofi Pasteur Limited
  •  Takeda Pharmaceutical Company Limited
  •  Merck Sharp & Dohme Corp
  •  GlaxoSmithKline plc
  •  GeneOne Life Science
  •  Medigen Vaccine Biologics
  •  Panacea Biotec Limited
  •  Sun Pharmaceutical Industries Ltd
  •  Serum Institute of India Pvt. Ltd
  •  Biological E
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Dengue Vaccine Market - By Product
1.3.2 Dengue Vaccine Market - By Distribution Channel
1.3.3 Dengue Vaccine Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. DENGUE VACCINE MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. DENGUE VACCINE MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. DENGUE VACCINE MARKET - GLOBAL MARKET ANALYSIS

6.1. DENGUE VACCINE - GLOBAL MARKET OVERVIEW
6.2. DENGUE VACCINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. DENGUE VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT

7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CYD-TDV
7.3.1. Overview
7.3.2. CYD-TDV Market Forecast and Analysis

8. DENGUE VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL

8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. DRUG STORES
8.5.1. Overview
8.5.2. Drug Stores Market Forecast and Analysis
8.6. ONLINE PHARMACIES
8.6.1. Overview
8.6.2. Online Pharmacies Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis

9. DENGUE VACCINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Dengue Vaccine Market Overview
9.1.2 North America Dengue Vaccine Market Forecasts and Analysis
9.1.3 North America Dengue Vaccine Market Forecasts and Analysis - By Product
9.1.4 North America Dengue Vaccine Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Dengue Vaccine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Dengue Vaccine Market
9.1.5.1.1 United States Dengue Vaccine Market by Product
9.1.5.1.2 United States Dengue Vaccine Market by Distribution Channel
9.1.5.2 Canada Dengue Vaccine Market
9.1.5.2.1 Canada Dengue Vaccine Market by Product
9.1.5.2.2 Canada Dengue Vaccine Market by Distribution Channel
9.1.5.3 Mexico Dengue Vaccine Market
9.1.5.3.1 Mexico Dengue Vaccine Market by Product
9.1.5.3.2 Mexico Dengue Vaccine Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Dengue Vaccine Market Overview
9.2.2 Europe Dengue Vaccine Market Forecasts and Analysis
9.2.3 Europe Dengue Vaccine Market Forecasts and Analysis - By Product
9.2.4 Europe Dengue Vaccine Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Dengue Vaccine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Dengue Vaccine Market
9.2.5.1.1 Germany Dengue Vaccine Market by Product
9.2.5.1.2 Germany Dengue Vaccine Market by Distribution Channel
9.2.5.2 France Dengue Vaccine Market
9.2.5.2.1 France Dengue Vaccine Market by Product
9.2.5.2.2 France Dengue Vaccine Market by Distribution Channel
9.2.5.3 Italy Dengue Vaccine Market
9.2.5.3.1 Italy Dengue Vaccine Market by Product
9.2.5.3.2 Italy Dengue Vaccine Market by Distribution Channel
9.2.5.4 Spain Dengue Vaccine Market
9.2.5.4.1 Spain Dengue Vaccine Market by Product
9.2.5.4.2 Spain Dengue Vaccine Market by Distribution Channel
9.2.5.5 United Kingdom Dengue Vaccine Market
9.2.5.5.1 United Kingdom Dengue Vaccine Market by Product
9.2.5.5.2 United Kingdom Dengue Vaccine Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Dengue Vaccine Market Overview
9.3.2 Asia-Pacific Dengue Vaccine Market Forecasts and Analysis
9.3.3 Asia-Pacific Dengue Vaccine Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Dengue Vaccine Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Dengue Vaccine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Dengue Vaccine Market
9.3.5.1.1 Australia Dengue Vaccine Market by Product
9.3.5.1.2 Australia Dengue Vaccine Market by Distribution Channel
9.3.5.2 China Dengue Vaccine Market
9.3.5.2.1 China Dengue Vaccine Market by Product
9.3.5.2.2 China Dengue Vaccine Market by Distribution Channel
9.3.5.3 India Dengue Vaccine Market
9.3.5.3.1 India Dengue Vaccine Market by Product
9.3.5.3.2 India Dengue Vaccine Market by Distribution Channel
9.3.5.4 Japan Dengue Vaccine Market
9.3.5.4.1 Japan Dengue Vaccine Market by Product
9.3.5.4.2 Japan Dengue Vaccine Market by Distribution Channel
9.3.5.5 South Korea Dengue Vaccine Market
9.3.5.5.1 South Korea Dengue Vaccine Market by Product
9.3.5.5.2 South Korea Dengue Vaccine Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Dengue Vaccine Market Overview
9.4.2 Middle East and Africa Dengue Vaccine Market Forecasts and Analysis
9.4.3 Middle East and Africa Dengue Vaccine Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Dengue Vaccine Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Dengue Vaccine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Dengue Vaccine Market
9.4.5.1.1 South Africa Dengue Vaccine Market by Product
9.4.5.1.2 South Africa Dengue Vaccine Market by Distribution Channel
9.4.5.2 Saudi Arabia Dengue Vaccine Market
9.4.5.2.1 Saudi Arabia Dengue Vaccine Market by Product
9.4.5.2.2 Saudi Arabia Dengue Vaccine Market by Distribution Channel
9.4.5.3 U.A.E Dengue Vaccine Market
9.4.5.3.1 U.A.E Dengue Vaccine Market by Product
9.4.5.3.2 U.A.E Dengue Vaccine Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Dengue Vaccine Market Overview
9.5.2 South and Central America Dengue Vaccine Market Forecasts and Analysis
9.5.3 South and Central America Dengue Vaccine Market Forecasts and Analysis - By Product
9.5.4 South and Central America Dengue Vaccine Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Dengue Vaccine Market Forecasts and Analysis - By Countries
9.5.5.1 Argentina Dengue Vaccine Market
9.5.5.1.1 Argentina Dengue Vaccine Market by Product
9.5.5.1.2 Argentina Dengue Vaccine Market by Distribution Channel

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. DENGUE VACCINE MARKET, KEY COMPANY PROFILES

11.1. SANOFI PASTEUR LIMITED
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. TAKEDA PHARMACEUTICAL COMPANY LIMITED
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. MERCK SHARP AND DOHME CORP
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLAXOSMITHKLINE PLC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GENEONE LIFE SCIENCE
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MEDIGEN VACCINE BIOLOGICS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PANACEA BIOTEC LIMITED
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SUN PHARMACEUTICAL INDUSTRIES LTD
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SERUM INSTITUTE OF INDIA PVT. LTD
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. BIOLOGICAL E
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

  1.  Sanofi Pasteur Limited
  2.  Takeda Pharmaceutical Company Limited
  3.  Merck Sharp & Dohme Corp
  4.  GlaxoSmithKline plc
  5.  GeneOne Life Science
  6.  Medigen Vaccine Biologics
  7.  Panacea Biotec Limited
  8.  Sun Pharmaceutical Industries Ltd
  9.  Serum Institute of India Pvt. Ltd
  10.  Biological E